Ameriprise
NUVL

Ameriprise’s Nuvalent NUVL Stock Holding History

Ameriprise’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.8M Sell
563,768
-530
-0.1% -$54K 0.01% 797
2025
Q4 		$56.8M Buy
564,298
+37,248
+7% +$3.67M 0.01% 810
2025
Q3 		$45.6M Buy
527,050
+42,707
+9% +$3.38M 0.01% 938
2025
Q2 		$37M Buy
484,343
+204,002
+73% +$14.9M 0.01% 1021
2025
Q1 		$19.9M Buy
280,341
+42,785
+18% +$3.35M 0.01% 1321
2024
Q4 		$18.6M Buy
237,556
+171,725
+261% +$16M ﹤0.01% 1380
2024
Q3 		$6.73M Buy
+65,831
New +$5.46M ﹤0.01% 2158
2023
Q4 		– Sell
-211,923
Closed -$9.74M – 3954
2023
Q3 		$9.74M Buy
+211,923
New +$9.41M ﹤0.01% 1724

Other funds holding NUVL

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise's NUVL Position: Q1 2026 in Review

Ameriprise reduced its Nuvalent (NUVL) stake by 0.09% in Q1 2026, selling an estimated $54K and leaving 563,768 shares worth $57.8M. The position accounts for 0.01% of the portfolio, ranked #797.

Ameriprise first reported a position in NUVL in Q3 2023 and has held it in 8 quarters since. 263 funds tracked by Wall St. Rank hold NUVL as of Q1 2026.

  • Ameriprise held 563,768 shares of Nuvalent worth $57.8M as of Q1 2026.
  • Ameriprise sold 530 Nuvalent shares in Q1 2026, an estimated $54K.
  • Nuvalent made up 0.01% of Ameriprise's portfolio in Q1 2026, its #797 holding.
  • Ameriprise first reported a position in Nuvalent in Q3 2023 and has held it in 8 quarters since.
  • 263 funds tracked by Wall St. Rank held Nuvalent as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.